Multifaceted roles of ASB proteins and its pathological significance

Abstract

BACKGROUND: Post-translational (PT) modification in cells regulates many intracellular events like signal transduction, transcription, cell cycle, protein quality control, apoptosis and cellular development. Ubiquitination is one of the PT modifications which functions as a marker for degradation of target proteins by the proteasome and as a regulatory mechanism for several signalling pathways. The ubiquitination mechanism requires multiple enzymes, including E1, E2, and E3 ligases. Among them, E3 ligases play a major role in recognizing target proteins and an essential feature of protein homeostatic mechanisms within the cell. Most of the ASB (ankyrin repeat SOCS box) proteins function as RING family of E3 ubiquitin ligases characterized by the presence of two conserved domains N-terminal ankyrin repeat and C-terminal SOCS box domain

METHODS and RESULTS: Current studies have shown that some ASBs function as important regulators of several signalling pathways. This review gives an overview of ASB proteins on numerous cellular processes such as insulin signalling, spermatogenesis, myogenesis and in cellular development. Including various pathological situations, such as cancer, primary open-angle glaucoma, and inflammation, indicating that ASBs has important functions in both normal and pathological development

CONCLUSIONS: This article provides a precise comprehensive focus on ASBs protein structure, its biological functions, and their pathological significance.

Keywords

ankyrin repeat / SOCS box / E3 ligase / cancer / spermatogenesis / cellular development

References

[1] Albertson D G, Collins C, McCormick F, Gray J W (2003). Chromosome aberrations in solid tumors. Nat Genet, 34(4): 369–376

[2] Andresen C A, Smedegaard S, Sylvestersen K B, Svensson C, Iglesias-Gato D, Cazzamali G, Nielsen T K, Nielsen M L, Flores-Morales A (2014). Protein interaction screening for the ankyrin repeats and suppressor of cytokine signaling (SOCS) box (ASB) family identify Asb11 as a novel endoplasmic reticulum resident ubiquitin ligase. J Biol Chem, 289(4): 2043–2054

[3] Au V, Tsang F H, Man K, Fan S T, Poon R T, Lee N P (2014). Expression of ankyrin repeat and SOCS box containing 4 (ASB4) confers migration and invasion properties of hepatocellular carcinoma cells. Biosci Trends, 8(2): 101–110

[4] Baer C, Claus R, Plass C (2013). Genome-wide epigenetic regulation of miRNAs in cancer. Cancer Res, 73(2): 473–477

[5] Bello N F, Lamsoul I, Heuzé M L, Métais A, Moreaux G, Calderwood D A, Duprez D, Moog-Lutz C, Lutz P G (2009). The E3 ubiquitin ligase specificity subunit ASB2b is a novel regulator of muscle differentiation that targets filamin B to proteasomal degradation. Cell Death Differ, 16(6): 921–932

[6] Ben-Baruch A (2006). Inflammation-associated immune suppression in cancer: the roles played by cytokines, chemokines and additional mediators. Seminars in cancer biology, Elsevier.

[7] Blenk S, Engelmann J, Weniger M, Schultz J, Dittrich M, Rosenwald A, Müller-Hermelink H K, Müller T, Dandekar T (2007). Germinal center B cell-like (GCB) and activated B cell-like (ABC) type of diffuse large B cell lymphoma (DLBCL): analysis of molecular predictors, signatures, cell cycle state and patient survival. Cancer Inform, 3: 399–420

[8] Bode M, Wu Y, Pi X, Lockyer P, Dechyapirom W, Portbury A L, Patterson C (2011). Regulation of ASB4 expression in the immortalized murine endothelial cell lines MS1 and SVR: a role for TNF-a and oxygen. Cell Biochem Funct, 29(4): 334

[9] Boengler K, Pipp F, Fernandez B, Richter A, Schaper W, Deindl E (2003). The ankyrin repeat containing SOCS box protein 5: a novel protein associated with arteriogenesis. Biochem Biophys Res Commun, 302(1): 17–22

[10] Bork P (1993). Hundreds of ankyrin-like repeats in functionally diverse proteins: mobile modules that cross phyla horizontally? Proteins, 17(4): 363–374

[11] Chung A S, Guan Y J, Yuan Z L, Albina J E, Chin Y E (2005). Ankyrin repeat and SOCS box 3 (ASB3) mediates ubiquitination and degradation of tumor necrosis factor receptor II. Mol Cell Biol, 25(11): 4716–4726

[12] Clermont Y (1972). Kinetics of spermatogenesis in mammals: seminiferous epithelium cycle and spermatogonial renewal. Physiol Rev, 52(1): 198–236

[13] Costa M L, Escaleira R, Cataldo A, Oliveira F, Mermelstein C S (2004). Desmin: molecular interactions and putative functions of the muscle intermediate filament protein. Braz J Med Biol Res, 37(12): 1819–1830

[14] Coussens L M, Werb Z (2002). Inflammation and cancer. Nature, 420(6917): 860–867

[15] Croker B A, Kiu H, Nicholson S E (2008). SOCS regulation of the JAK/STAT signalling pathway. Seminars in cell & developmental biology, Elsevier.

[16] Crosetto N, Bienko M, Dikic I (2006). Ubiquitin hubs in oncogenic networks. Mol Cancer Res, 4(12): 899–904

[17] da Silva M A S,Peppelenbosch M P(2003). Size matters: the emerging role of ASB proteins in controlling cell fate decisions and cancer development. Werking en functie van ASB eiwitten in de regulatie van compartimentgrootte: 15.

[18] Debrincat M A, Zhang J G, Willson T A, Silke J, Connolly L M, Simpson R J, Alexander W S, Nicola N A, Kile B T, Hilton D J (2007). Ankyrin repeat and suppressors of cytokine signaling box protein asb-9 targets creatine kinase B for degradation. J Biol Chem, 282(7): 4728–4737

[19] Diks S H, Bink R J, van de Water S, Joore J, van Rooijen C, Verbeek F J, den Hertog J, Peppelenbosch M P, Zivkovic D (2006). The novel gene asb11: a regulator of the size of the neural progenitor compartment. J Cell Biol, 174(4): 581–592

[20] Du W Y, Lu Z H, Ye W, Fu X, Zhou Y, Kuang C M, Wu J X, Pan Z Z, Chen S, Liu R Y, Huang W L (2017). The loss-of-function mutations and down-regulated expression of ASB3 gene promote the growth and metastasis of colorectal cancer cells. Chin J Cancer, 36(1): 11

[21] Fei X, Gu X, Fan S, Yang Z, Li F, Zhang C, Gong W, Mao Y, Ji C (2012). Crystal structure of Human ASB9-2 and substrate-recognition of CKB. Protein J, 31(4): 275–284

[22] Ferguson J 3rd,Wu Y(2007). Ankyrin repeat and SOCS Box Protein 4 (ASB4) is a hydroxylation substrate of factor inhibiting HIF1 {alpha}(FIH) and promotes vascular differentiation via an oxygen-dependent mechanism. Cell Signal, 19(6):1185–92

[23] Ferguson J E 3rd, Wu Y, Smith K, Charles P, Powers K, Wang H, Patterson C (2007). ASB4 is a hydroxylation substrate of FIH and promotes vascular differentiation via an oxygen-dependent mechanism. Mol Cell Biol, 27(18): 6407–6419

[24] Foord R, Taylor I A, Sedgwick S G, Smerdon S J (1999). X-ray structural analysis of the yeast cell cycle regulator Swi6 reveals variations of the ankyrin fold and has implications for Swi6 function. Nat Struct Biol, 6(2): 157–165

[25] Groothuis T A, Dantuma N P, Neefjes J, Salomons F A (2006). Ubiquitin crosstalk connecting cellular processes. Cell Div, 1(1): 21

[26] Guibal F C, Moog-Lutz C, Smolewski P, Di Gioia Y, Darzynkiewicz Z, Lutz P G, Cayre Y E (2002). ASB-2 inhibits growth and promotes commitment in myeloid leukemia cells. J Biol Chem, 277(1): 218–224

[27] Guo J H, Saiyin H, Wei Y H, Chen S, Chen L, Bi G, Ma L J, Zhou G J, Huang C Q, Yu L, Dai L (2004). Expression of testis specific ankyrin repeat and SOCS box-containing 17 gene. Arch Androl, 50(3): 155–161

[28] Hilton D J (1999). Negative regulators of cytokine signal transduction. Cell Mol Life Sci, 55(12): 1568–1577

[29] Hilton D J, Richardson R T, Alexander W S, Viney E M, Willson T A, Sprigg N S, Starr R, Nicholson S E, Metcalf D, Nicola N A (1998). Twenty proteins containing a C-terminal SOCS box form five structural classes. Proc Natl Acad Sci USA, 95(1): 114–119

[30] Hirokawa N, Noda Y, Tanaka Y, Niwa S (2009). Kinesin superfamily motor proteins and intracellular transport. Nat Rev Mol Cell Biol, 10(10): 682–696

[31] Hotamisligil G S (2006). Inflammation and metabolic disorders. Nature, 444(7121): 860–867

[32] Jang C Y, Wong J, Coppinger J A, Seki A, Yates J R 3rd, Fang G (2008). DDA3 recruits microtubule depolymerase Kif2a to spindle poles and controls spindle dynamics and mitotic chromosome movement. J Cell Biol, 181(2): 255–267

[33] Johnson D G, Walker C L (1999). Cyclins and cell cycle checkpoints. Annu Rev Pharmacol Toxicol, 39(1): 295–312

[34] Kamura T, Sato S, Haque D, Liu L, Kaelin W G Jr, Conaway R C, Conaway J W (1998). The Elongin BC complex interacts with the conserved SOCS-box motif present in members of the SOCS, ras, WD-40 repeat, and ankyrin repeat families. Genes Dev, 12(24): 3872–3881

[35] Keller K E, Wirtz M K (2016). Working your SOCS off: The role of ASB10 and protein degradation pathways in glaucoma. Exp Eye Res

[36] Kile B T, Schulman B A, Alexander W S, Nicola N A, Martin H M, Hilton D J (2002). The SOCS box: a tale of destruction and degradation. Trends Biochem Sci, 27(5): 235–241

[37] Kim K S, Kim M S, Kim S K, Baek K H (2004). Murine Asb-17 expression during mouse testis development and spermatogenesis. Zygote, 12(2): 151–156

[38] Kim S K, Rhim S Y, Lee M R,Kim J S, Kim H J, Lee D R, Kim K S (2008). Stage-specific expression of ankyrin and SOCS box protein-4 (Asb-4) during spermatogenesis. Mol Cell, 25(2):317–21

[39] Kohroki J, Nishiyama T, Nakamura T, Masuho Y (2005). ASB proteins interact with Cullin5 and Rbx2 to form E3 ubiquitin ligase complexes. FEBS Lett, 579(30): 6796–6802

[40] Lai K C, Chang K W, Liu C J, Lee T C (2006). Enhanced expression of ASB6 and IFIT2 in oral squamous cell carcinoma, AACR.

[41] Lamsoul I, Burande C F, Razinia Z, Houles T C, Menoret D, Baldassarre M, Erard M, Moog-Lutz C, Calderwood D A, Lutz P G (2011). Functional and structural insights into ASB2a, a novel regulator of integrin-dependent adhesion of hematopoietic cells. J Biol Chem, 286(35): 30571–30581

[42] Lee M R,Kim S K, Kim J S, Rhim S Y,Kim K S (2008). Expression of murine Asb-9 during mouse spermatogenesis. Mol Cell, 26(6):621–4

[43] Lee N P, Leung K W, Cheung N, Lam B Y, Xu M Z, Sham P C, Lau G K, Poon R T, Fan S T, Luk J M (2008). Comparative proteomic analysis of mouse livers from embryo to adult reveals an association with progression of hepatocellular carcinoma. Proteomics, 8(10): 2136–2149

[44] Li J, Mahajan A, Tsai M D (2006). Ankyrin repeat: a unique motif mediating protein-protein interactions. Biochemistry, 45(51): 15168–15178

[45] Li J Y, Chai B, Zhang W, Wu X, Zhang C, Fritze D, Xia Z, Patterson C, Mulholland M W (2011). Ankyrin repeat and SOCS box containing protein 4 (Asb-4) colocalizes with insulin receptor substrate 4 (IRS4) in the hypothalamic neurons and mediates IRS4 degradation. BMC Neurosci, 12(1): 95

[46] Linossi E M, Nicholson S E (2012). The SOCS box-adapting proteins for ubiquitination and proteasomal degradation. IUBMB Life, 64(4): 316–323

[47] Liu Y, Li J, Zhang F, Qin W, Yao G, He X, Xue P, Ge C, Wan D, Gu J (2003). Molecular cloning and characterization of the human ASB-8 gene encoding a novel member of ankyrin repeat and SOCS box containing protein family. Biochem Biophys Res Commun, 300(4): 972–979

[48] Lux S E, John K M, Bennett V (1990). Analysis of cDNA for human erythrocyte ankyrin indicates a repeated structure with homology to tissue-differentiation and cell-cycle control proteins.   Nature 344(6261):36–42

[49] Marcotte E M, Pellegrini M, Yeates T O, Eisenberg D (1999). A census of protein repeats. J Mol Biol, 293(1): 151–160

[50] Maxwell P H, Wiesener M S, Chang G W, Clifford S C, Vaux E C, Cockman M E, Wykoff C C, Pugh C W, Maher E R, Ratcliffe P J (1999). The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature, 399(6733): 271–275

[51] McDaneld T G, Hannon K, Moody D E (2006). Ankyrin repeat and SOCS box protein 15 regulates protein synthesis in skeletal muscle. Am J Physiol Regul Integr Comp Physiol, 290(6): R1672–R1682

[52] McDaneld T G, Spurlock D M (2008). Ankyrin repeat and suppressor of cytokine signaling (SOCS) box-containing protein (ASB) 15 alters differentiation of mouse C2C12 myoblasts and phosphorylation of mitogen-activated protein kinase and Akt. J Anim Sci, 86(11): 2897–2902

[53] Mocellin S, Rossi C R, Pilati P, Nitti D (2005). Tumor necrosis factor, cancer and anticancer therapy. Cytokine Growth Factor Rev, 16(1): 35–53

[54] Morris L G, Veeriah S, Chan T A (2010). Genetic determinants at the interface of cancer and neurodegenerative disease. Oncogene, 29(24): 3453–3464

[55] Mosavi L K, Cammett T J, Desrosiers D C, Peng Z Y (2004). The ankyrin repeat as molecular architecture for protein recognition. Protein Sci, 13(6): 1435–1448

[56] Mosavi L K, Minor D L Jr, Peng Z Y (2002). Consensus-derived structural determinants of the ankyrin repeat motif. Proc Natl Acad Sci USA, 99(25): 16029–16034

[57] Nie L, Zhao Y, Wu W, Yang Y Z, Wang H C, Sun X H (2011). Notch-induced Asb2 expression promotes protein ubiquitination by forming non-canonical E3 ligase complexes. Cell Res, 21(5): 754–769

[58] Okumura F, Matsuzaki M, Nakatsukasa K, Kamura T (2012).The role of elongin BC-containing ubiquitin ligases. Front Oncol, 2: 10

[59] Pahl H L (1999). Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene, 18(49): 6853–6866

[60] Plum L, Belgardt B F, Brüning J C (2006). Central insulin action in energy and glucose homeostasis. J Clin Invest, 116(7): 1761–1766

[61] Seki A, Coppinger J A, Jang C Y, Yates J R, Fang G (2008). Bora and the kinase Aurora a cooperatively activate the kinase Plk1 and control mitotic entry. Science, 320(5883): 1655–1658

[62] Sonnhammer E L, Von Heijne G, Krogh A (1998). A hidden Markov model for predicting transmembrane helices in protein sequences. Proc Int Conf Intell Syst Mol Biol, 6:175–82

[63] Tee J M, Peppelenbosch M P (2010). Anchoring skeletal muscle development and disease: the role of ankyrin repeat domain containing proteins in muscle physiology. Crit Rev Biochem Mol Biol, 45(4): 318–330

[64] Tee J M, Sartori da Silva M A, Rygiel A M, Muncan V, Bink R, van den Brink G R, van Tijn P, Zivkovic D, Kodach L L, Guardavaccaro D, Diks S H, Peppelenbosch M P (2012). asb11 is a regulator of embryonic and adult regenerative myogenesis. Stem Cells Dev, 21(17): 3091–3103

[65] Thomas J C, Matak-Vinkovic D, Van Molle I, Ciulli A (2013). Multimeric complexes among ankyrin-repeat and SOCS-box protein 9 (ASB9), ElonginBC, and Cullin 5: insights into the structure and assembly of ECS-type Cullin-RING E3 ubiquitin ligases. Biochemistry, 52(31): 5236–5246

[66] Thottakara T, Friedrich F W, Reischmann S, Braumann S, Schlossarek S, Krämer E, Juhr D, Schlüter H, van der Velden J, Münch J, Patten M, Eschenhagen T, Moog-Lutz C, Carrier L (2015). The E3 ubiquitin ligase Asb2b is downregulated in a mouse model of hypertrophic cardiomyopathy and targets desmin for proteasomal degradation. J Mol Cell Cardiol, 87: 214–224

[67] Tokuoka M, Miyoshi N, Hitora T, Mimori K, Tanaka F, Shibata K, Ishii H, Sekimoto M, Doki Y, Mori M (2010). Clinical significance of ASB9 in human colorectal cancer. Int J Oncol, 37(5): 1105–1111

[68] Townley-Tilson W H, Wu Y, Ferguson J E 3rd, Patterson C (2014). The ubiquitin ligase ASB4 promotes trophoblast differentiation through the degradation of ID2. PLoS One, 9(2): e89451

[69] Uematsu K, Okumura F, Tonogai S, Joo-Okumura A, Alemayehu D H, Nishikimi A, Fukui Y, Nakatsukasa K, Kamura T (2016). ASB7 regulates spindle dynamics and genome integrity by targeting DDA3 for proteasomal degradation. J Cell Biol, 215(1): 95–106

[70] van Kouwenhove M, Kedde M, Agami R (2011). MicroRNA regulation by RNA-binding proteins and its implications for cancer. Nat Rev Cancer, 11(9): 644–656

[71] Wajant H, Pfizenmaier K, Scheurich P (2003). Tumor necrosis factor signaling. Cell Death Differ, 10(1): 45–65

[72] Wang J, Muntean A G, Hess J L (2012). ECSASB2 mediates MLL degradation during hematopoietic differentiation. Blood, 119(5): 1151–1161

[73] Wauman J, De Smet A S, Catteeuw D, Belsham D, Tavernier J (2008). Insulin receptor substrate 4 couples the leptin receptor to multiple signaling pathways. Mol Endocrinol, 22(4): 965–977

[74] Wilcox A, Katsanakis K D, Bheda F, Pillay T S (2004). Asb6, an adipocyte-specific ankyrin and SOCS box protein, interacts with APS to enable recruitment of elongins B and C to the insulin receptor signaling complex. J Biol Chem, 279(37): 38881–38888

[75] Wilcox G (2005). Insulin and insulin resistance. Clin Biochem Rev, 26(2): 19–39

[76] Yang X Y, Ren C P, Wang L, Li H, Jiang C J, Zhang H B, Zhao M, Yao K T (2005). Identification of differentially expressed genes in metastatic and non-metastatic nasopharyngeal carcinoma cells by suppression subtractive hybridization. Cell Oncol, 27(4): 215–223

[77] Yuan J H, Yang F, Chen B F, Lu Z, Huo X S, Zhou W P, Wang F, Sun S H (2011). The histone deacetylase 4/SP1/microrna-200a regulatory network contributes to aberrant histone acetylation in hepatocellular carcinoma. Hepatology, 54(6): 2025–2035

[78] Ziemin-van der Poel S, McCabe N R, Gill H J, Espinosa R 3rd, Patel Y, Harden A, Rubinelli P, Smith S D, LeBeau M M, Rowley J D (1991). Identification of a gene, MLL, that spans the breakpoint in 11q23 translocations associated with human leukemias. Proc Natl Acad Sci USA, 88(23): 10735–10739

Acknowledgements

The authors wish to greatly acknowledge VIT University. This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sector. The authors wish to thank Navin Kumar B for his help in the manuscript proof reading.

Compliance with ethical standards

The authors declare no conflicts of interests and the project was funded by no third party. Humans/Animal research were not involved in any part of the research.

RIGHTS & PERMISSIONS

2018 Higher Education Press and Springer-Verlag GmbH Germany, part of Springer Nature